Sponsor or institution
Clinical trials and research at Glycomantra, INC.
As of November 12, 2026, Find a Trial lists 2 NIH-funded research projects at this institution, with $2.2 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2NIH research projects
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Using a natural compound to improve insulin sensitivity in type 2 diabetes
This study is looking at a new treatment for type 2 diabetes that targets a protein called galectin-3, using a natural compound called TFD100, to help improve insulin resistance and potentially offer a new option for managing the condition.
-
Targeting a protein to help older adults with COVID-19
This study is looking at a protein called galectin-3 to see how it might help the COVID-19 virus stick to cells, especially in older adults and people with diabetes or high blood pressure, to find out if targeting this protein could help reduce the risk of severe illness from COVID-19.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.